← Leaderboards
Benjamin Solomon Freedman
Brigham And Women'S Hospital
$9,899,767
Attributed
$13,217,470
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,767,002 · 17
By mechanism
U2C$6,815,843 · 6
U01$3,910,295 · 3
R01$2,988,447 · 2
R42$839,264 · 1
UH3$778,292 · 1
K01$743,020 · 1
Top collaborators
- Jonathan Himmelfarb8 shared
- Edward J Kelly7 shared
- Shreeram Akilesh3 shared
- Kelly D Smith3 shared
- Matthias Kretzler1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Ofer Levy$23,792,522
- Jonathan Li$17,759,976
- Anna Greka$12,512,557
- Pamela Vivian Tran$4,737,119
- Richard Carl Krolewski$738,683
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyOrganoidsCellsPhenotypeIn VitroCell LineKidney DiseasesArchitectureIn VivoEpithelial CellsInnovationGenesAnimal ModelCell TypeTissuesComplexLifeStructureTubular FormationMolecularMutationPre-Clinical ModelHuman TissueSafety
Grant awards (37)
Translational center for kidney microphysiological systems to improve drug safety and efficacy$1,612,823
U2C · FY2025 · TR
Targeting Myosin to Treat Polycystic Kidney Disease$839,264
R42 · FY2025 · DK · contact PI
Core-001$725,771
U2C · FY2025 · TR
Core-003$725,770
U2C · FY2025 · TR
Polycystic Kidney Disease In Vitro Center (PKD-InVent)$414,267
U54 · FY2025 · DK · contact PI
Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics$341,841
U01 · FY2025 · AI · contact PI
Administrative Core$103,136
U54 · FY2025 · DK · contact PI
Professional Development Core$96,519
U2C · FY2025 · DK · contact PI
Translational center for kidney microphysiological systems to improve drug safety and efficacy$1,522,442
U2C · FY2024 · TR
Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems$778,292
UH3 · FY2024 · TR · contact PI
MPS Resources Section$610,076
U2C · FY2024 · TR · contact PI
Admin-Core-002$507,481
U2C · FY2024 · TR
Core-001$507,481
U2C · FY2024 · TR
Core-003$507,480
U2C · FY2024 · TR
Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics$346,783
U01 · FY2024 · AI · contact PI
Mechanisms of Kidney Injury in COVID-19$406,985
R01 · FY2023 · DK
Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics$351,725
U01 · FY2023 · AI · contact PI
Improving the Safety of Genome Editing With Human Kidney Organoids$652,815
U01 · FY2022 · DK · contact PI
Mechanisms of Kidney Injury in COVID-19$408,109
R01 · FY2022 · DK
A Human Organoid Model of Polycystic Kidney Disease$353,000
R01 · FY2022 · DK · contact PI
Improving the Safety of Genome Editing With Human Kidney Organoids$665,847
U01 · FY2021 · DK · contact PI
Mechanisms of Kidney Injury in COVID-19$409,186
R01 · FY2021 · DK
A Human Organoid Model of Polycystic Kidney Disease$353,000
R01 · FY2021 · DK · contact PI
SCGE Comparative Studies Supplement$158,307
U01 · FY2021 · DK · contact PI
Improving the Safety of Genome Editing With Human Kidney Organoids$679,632
U01 · FY2020 · DK · contact PI
A Human Organoid Model of Polycystic Kidney Disease$353,000
R01 · FY2020 · DK · contact PI
Improving the Safety of Genome Editing With Human Kidney Organoids$713,345
U01 · FY2019 · EB · contact PI
A Human Organoid Model of Polycystic Kidney Disease$353,000
R01 · FY2019 · DK · contact PI
A Human Organoid Model of Polycystic Kidney Disease$352,167
R01 · FY2018 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$146,264
K01 · FY2018 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$146,264
K01 · FY2017 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$146,264
K01 · FY2016 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$146,264
K01 · FY2015 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$157,964
K01 · FY2014 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$60,170
F32 · FY2013 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$58,442
F32 · FY2012 · DK · contact PI
Modeling Polycystic Kidney Disease Using Human Induced Pluripotent Stem Cells$55,826
F32 · FY2011 · DK · contact PI